More Than 200 New Drugs Developed By International Players Encounter Approval Delays in Turkey

A major grouping of pharmaceutical makers in Turkey said that a new government rule requiring separate good manufacturing practice certification from the Ministry of Health has delayed approval for 287 new drugs manufactured by international firms

More from Archive

More from Scrip